Weichuan Mo, PhD

Director of Pre-clinical Research
Beijing Gensciences Inc., Beijing, China
Beijing, Beijing, China (People's Republic)

Weichuan Mo, PhD, Director of Preclinical Research, Beijing Gensciences lnc., Beijing Economic-Technological Development Area, Beijing, China (People's Republic).
Research experience:
2020-present: In charge of the pre-clinical researches of Hemophilia pipelines: Long-acting FVIII, FVIIa and FIX; FVIIIa-mimetic bispecific antibody
2011-2017: Post-doctor, The State key laboratory of brain and cognitive science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
2011-2013: Research Officer, The University of Queensland, Brisbane, Queensland 4072, Australia (QBI-IBP joint lab)

Presentation(s):

• OC 21.3 - The in vitro and in vivo hemostatic efficacies of a novel FVIIIa-mimetic bispecific antibody, SS315, for the treatment of Hemophilia A.

  Sunday, June 23, 2024
  15:15 – 15:30 ICT